Comparison of the efficacy between infliximab intravenous vs. subcutaneous in ulcerative colitis
Not Applicable
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0007789
- Lead Sponsor
- Kyungpook National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 54
Inclusion Criteria
Moderate to severe ulcerative colitis
Exclusion Criteria
Patients who were exposed to other biologics.
Patients who underwent bowel surgery.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical remission
- Secondary Outcome Measures
Name Time Method Clinical response